FAS and metastatic neoplasm: Although the elimination of CD95 expression in some colorectal tumors was reported to predict metastatic tumor recurrence (135), most of the analyses indicate that CD95 expression is maintained in these tumors and contributes to activate pro-oncogenic signaling pathways (136).